Clinical trial

A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

NCT05888831

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-06-06

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-06-06Date precision: day

Registry last updated2025-06-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorsunresolved

Interventions

BMS-986449DRUG

NivolumabDRUG · verified · RxNorm: nivolumab

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

MadridSpain2 Los AngelesCalifornia, United States1 New HavenConnecticut, United States1 RomaItaly1 BordeauxFrance1 GroningenNetherlands1 HackensackNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05888831 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.